ranQ
ranQ
ranQ
DirectoryIndustriesPlacesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The leading AI company directory, built to boost AI visibility.

DEENFRIT
Product
  • Pricing
  • Directory
  • Industries
  • Trust Score
Company
  • About
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint745,629 companies indexed · Last updated: today
DirectoryIndustryPharmaceutical IndustryGenevaMPC Therapeutics SA
MPC Therapeutics SA Logo
Verified· 3 sourcesTrust Score
Summary

About the company

The core activity of MPC Therapeutics SA is the development of innovative products that improve the fitness, persistence and performance of cells, particularly T cells, mesenchymal stem cells (MSCs) and hematopoietic stem cells (HSCs). This is achieved through modulation of mitochondrial function, specifically by targeted influence on the mitochondrial pyruvate carrier (MPC) and other key metabolic pathways. The company develops small molecules that modulate mitochondrial function to enhance the therapeutic efficacy of cell therapies.

AI-generated
Offering

Products & services

Industry:Pharmaceutical Industry
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
4.1/5

MPC Therapeutics SA

✓ Offered3
MitoRange products
Metabolic enhancers for cell therapies, including MitoStem™, MitoGrow™ and MitoFit™; reagents for T-cell fitness, CAR-T expansion and metabolic modulation.
Metabolic modulation for cell therapies
Small-molecule metabolic modulation solutions to improve quality, durability and persistence of cell therapies, with applications for immune cells, stem cells and biomanufacturing.
Partnerships for the translation of cell therapy technologies
Collaborations with cell therapy developers and biomanufacturing leaders to translate metabolic modulation into scalable solutions for preclinical, RUO and GMP contexts.
Trust & reputation

ranQ Trust Score of MPC Therapeutics SA: 4.1 out of 5.0

Trust Score4.1/ 5.0

High

x

Data basis 58% · As of October 2026

MPC Therapeutics SA has no value in the Reputation area of the ranQ Trust Score because no data is available. The area carries 42% of the weighting and drops out of the calculation for this profile; it does not lower the score, only the reported data basis.
x
CriterionValueWeight
  • Review quality: No data point — the criterion is taken out of the weighting and does not lower the score.—24%
  • Review volume: No data point — the criterion is taken out of the weighting and does not lower the score.—10%
  • Review recency: No data point — the criterion is taken out of the weighting and does not lower the score.—8%
MPC Therapeutics SA scores 80.4 out of 100 points in the Substance area of the ranQ Trust Score. This area carries 28% of the weighting.
x
CriterionValueWeight
  • Establishment: Years since founding or brand launch, logarithmic. The maximum is reached at 15 years.79.212%
  • Company size: The headcount band, researched by ranQ or stated by the company. It is scored in steps rather than by head count, because the data only provides bands.70.07%
MPC Therapeutics SA scores 86.7 out of 100 points in the Identity area of the ranQ Trust Score. This area carries 22% of the weighting.
x
CriterionValueWeight
  • Verification: Official register entry (commercial register with UID or professional-body record, 55 points), confirmed domain (20 points) and confirmed ranQ profile (up to 25 points, depending on completeness).86.722%
MPC Therapeutics SA scores 16.5 out of 100 points in the Visibility area of the ranQ Trust Score. This area carries 8% of the weighting.
x
CriterionValueWeight
  • Website authority: Ahrefs' Domain Rating measures, on a scale of 0 to 100, how strongly a website is linked from other websites. For Swiss SMEs the range up to 40 is typical; the maximum is reached at 35.22.94%
  • Media authority: Quality and number of editorial mentions, weighted by the importance of the source, plus the recency of the latest high-quality mention.10.04%
Qualifications+0.00

MPC Therapeutics SA reaches a ranQ Trust Score of 4.1 out of 5.0 — rated «High». No public customer reviews are available for this provider; the rating is based on the remaining criteria. The data basis is 58%, so the score is backed by part of the criteria. As of October 2026.

The Trust Score cannot be bought and is calculated from publicly verifiable data.

Press

Media

January 10, 2023Media
CHF 1.5M for MPC Therapeutics Expanding Pipeline
startupticker.ch

Knowledge

No knowledge articles yet

Once MPC Therapeutics SA has claimed this profile, we'll publish editorial articles and case studies here together.

Get started
Comparisons

MPC Therapeutics SA in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank MPC Therapeutics SA by reviews, experience and specialisations.

Is this your company?

Claim the company profile of MPC Therapeutics SA to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Route de Florissant 53
1206 Geneva

At a glance

Legal form
Corporation
UID
CHE-432.161.098
Founded
2018 · 8 years
Last commercial register change
August 28, 2026
Employees
11 to 20
Legal form: Graded by liability and disclosure. The weight is kept small: a sole proprietorship is not a dubious company, it is just liable differently.
100.0
6%
  • Branch offices: Branch offices linked in the commercial register. Having none is normal and costs no points.70.03%
    • Full methodology

    Similar companies

    AS
    Ageronix SA
    Carouge Ge
    KB
    KBI Biopharma SA
    Plan-Les-Ouates
    OP
    OM Pharma SA
    Meyrin
    MM
    MMV MEDICINES FOR MALARIA VENTURE
    Cointrin
    IT
    IREMIS Therapeutics SA
    Anières
    IS
    Impingo Sàrl
    Meyrin
    SG
    SANOFI GESTION SA
    Vernier
    LP
    Labatec Pharma SA
    Meyrin